Denis Lane

1.4k total citations
26 papers, 1.1k citations indexed

About

Denis Lane is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Denis Lane has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Immunology and 7 papers in Oncology. Recurrent topics in Denis Lane's work include Cell death mechanisms and regulation (10 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Denis Lane is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Denis Lane collaborates with scholars based in Canada, Belgium and France. Denis Lane's co-authors include Alain Piché, Claudine Rancourt, Isabelle Matte, Claude Laplante, Perrine Garde‐Granger, Marianne Boivin, Véronique Robert, Alex Carignan, Marceline Côté and Paul Bessette and has published in prestigious journals such as Critical Care Medicine, Infection and Immunity and International Journal of Cancer.

In The Last Decade

Denis Lane

26 papers receiving 1.1k citations

Peers

Denis Lane
Mark G. Cadungog United States
Michele Cummings United Kingdom
Julian A. Gingold United States
Zara Zelenko United States
Denis Lane
Citations per year, relative to Denis Lane Denis Lane (= 1×) peers Isabelle Matte

Countries citing papers authored by Denis Lane

Since Specialization
Citations

This map shows the geographic impact of Denis Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Lane more than expected).

Fields of papers citing papers by Denis Lane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Lane. The network helps show where Denis Lane may publish in the future.

Co-authorship network of co-authors of Denis Lane

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Lane. A scholar is included among the top collaborators of Denis Lane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Lane. Denis Lane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2018). Ascites IL-10 Promotes Ovarian Cancer Cell Migration. Cancer Microenvironment. 11(2-3). 115–124. 26 indexed citations
2.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2016). CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Molecular Cancer. 15(1). 58–58. 57 indexed citations
3.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, et al.. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer. 15(1). 492–492. 62 indexed citations
4.
Matte, Isabelle, Denis Lane, Dimcho Bachvarov, Claudine Rancourt, & Alain Piché. (2014). Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer. 14(1). 288–288. 31 indexed citations
5.
Matte, Isabelle, Denis Lane, Marianne Boivin, Claudine Rancourt, & Alain Piché. (2014). MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression. BMC Cancer. 14(1). 234–234. 31 indexed citations
6.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2013). Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis. Journal of Ovarian Research. 6(1). 82–82. 33 indexed citations
7.
Matte, Isabelle, et al.. (2012). Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Molecular Cancer. 11(1). 84–84. 42 indexed citations
8.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2012). Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. Journal of Ovarian Research. 5(1). 34–34. 37 indexed citations
9.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2011). Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer. 11(1). 210–210. 148 indexed citations
10.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2010). The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. Journal of Ovarian Research. 3(1). 1–1. 44 indexed citations
11.
Matte, Isabelle, et al.. (2009). Antiapoptotic Proteins Bcl-2 and Bcl-X L Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells. Infection and Immunity. 77(12). 5400–5410. 26 indexed citations
12.
Boivin, Marianne, Denis Lane, Alain Piché, & Claudine Rancourt. (2009). CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecologic Oncology. 115(3). 407–413. 75 indexed citations
13.
Lane, Denis, et al.. (2007). Malignant ascites protect against TRAIL‐induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells. International Journal of Cancer. 121(6). 1227–1237. 81 indexed citations
14.
Bélanger, Sylvie, Marceline Côté, Denis Lane, et al.. (2005). Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells. Gynecologic Oncology. 97(3). 796–806. 25 indexed citations
15.
Lesur, Olivier, et al.. (2004). Role of IFN-γ and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(1). L4–L14. 18 indexed citations
16.
Lesur, Olivier, et al.. (2000). Interleukin-2 involvement in early acute respiratory distress syndrome: Relationship with polymorphonuclear neutrophil apoptosis and patient survival. Critical Care Medicine. 28(12). 3814–3822. 34 indexed citations
17.
Nadeau, Denis & Denis Lane. (1989). On the cytotoxicity of chrysotile asbestos fibers toward pulmonary alveolar macrophages. Toxicology and Applied Pharmacology. 98(1). 144–158. 2 indexed citations
18.
Lane, Denis & Denis Nadeau. (1988). Determination of pyridine nucleotide contents of cell monolayers by bioluminescence. Journal of Biochemical and Biophysical Methods. 17(2). 107–117. 6 indexed citations
19.
Nadeau, Denis & Denis Lane. (1988). The cytotoxicity of chrysotile asbestos fibers to pulmonary alveolar macrophages I. Effects of inhibitors of ADP-ribosyl transferase. Cell Biology and Toxicology. 4(1). 13–30. 5 indexed citations
20.
Nadeau, Denis, et al.. (1987). Cytotoxicity of Respirable Dusts Fron Industrial Hinerals: Comparison of Two Naturally Occurring and Two Man-Made Silicates. Drug and Chemical Toxicology. 10(1-2). 49–86. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026